Zhenyu  Xu net worth and biography

Zhenyu Xu Biography and Net Worth

Insider of SOPHiA GENETICS

Zhenyu Xu, Ph. D., is a genome scientist with a background in molecular and computational biology. Zhenyu is among the most experienced bioinformaticians in clinical NGS data analysis worldwide. He joined SOPHiA GENETICS in January 2012 and is the leader of the technology team that developed the SOPHiA DDM™ platform – the universal technology for data-driven medicine.

Zhenyu has served as our Chief Scientific Officer since January 2021 and was previously our Chief Technology Officer since May 2014. Prior to that, Zhenyu was a post-doctoral fellow at the European Molecular Biology Laboratory.

Zhenyu holds an M.Sc. in molecular and computational biology from Cambridge University and obtained his Ph.D. at the European Molecular Biology Laboratory, where he focused on the transcriptome landscape of yeast. His Ph.D. work systematically characterized the non-coding transcripts in yeast that lead to the unveiling that, in a majority of cases, transcriptions are bidirectional.

What is Zhenyu Xu's net worth?

The estimated net worth of Zhenyu Xu is at least $3.21 million as of April 20th, 2026. Xu owns 630,888 shares of SOPHiA GENETICS stock worth more than $3,211,851 as of May 5th. This net worth estimate does not reflect any other assets that Xu may own. Learn More about Zhenyu Xu's net worth.

How do I contact Zhenyu Xu?

The corporate mailing address for Xu and other SOPHiA GENETICS executives is , , . SOPHiA GENETICS can also be reached via phone at 41-21-694-1060. Learn More on Zhenyu Xu's contact information.

Has Zhenyu Xu been buying or selling shares of SOPHiA GENETICS?

In the last ninety days, Zhenyu Xu has sold $92,016.04 in SOPHiA GENETICS stock. Most recently, Zhenyu Xu sold 608 shares of the business's stock in a transaction on Monday, April 20th. The shares were sold at an average price of $5.21, for a transaction totalling $3,167.68. Following the completion of the sale, the insider now directly owns 630,888 shares of the company's stock, valued at $3,286,926.48. Learn More on Zhenyu Xu's trading history.

Who are SOPHiA GENETICS's active insiders?

SOPHiA GENETICS's insider roster includes Jurgi Camblong (Founder and CEO), George Cardoza (EVP – Chief Financial Officer), Philippe Menu (Insider), Ross Muken (President), Kevin Puylaert (SVP, Chief Sales Officer), Manuela Valente (Insider), Well Van (Insider), Abhimanyu Verma (EVP, Chief Technology Officer), and Zhenyu Xu (Insider). Learn More on SOPHiA GENETICS's active insiders.

Are insiders buying or selling shares of SOPHiA GENETICS?

In the last twelve months, insiders at the sold shares 57 times. They sold a total of 193,859 shares worth more than $943,777.03. The most recent insider tranaction occured on April, 27th when insider Philippe Menu sold 5,000 shares worth more than $24,100.00. Insiders at SOPHiA GENETICS own 4.9% of the company. Learn More about insider trades at SOPHiA GENETICS.

Information on this page was last updated on 4/27/2026.

Zhenyu Xu Insider Trading History at SOPHiA GENETICS

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/20/2026Sell608$5.21$3,167.68630,888View SEC Filing Icon  
4/14/2026Sell600$4.97$2,982.00631,496View SEC Filing Icon  
4/13/2026Sell4,414$4.76$21,010.64632,096View SEC Filing Icon  
4/10/2026Sell3,706$4.68$17,344.08636,510View SEC Filing Icon  
4/9/2026Sell1,936$4.74$9,176.64640,216View SEC Filing Icon  
4/8/2026Sell2,800$4.84$13,552.00642,152View SEC Filing Icon  
4/7/2026Sell2,400$4.87$11,688.00644,952View SEC Filing Icon  
4/6/2026Sell2,700$4.85$13,095.00647,352View SEC Filing Icon  
3/19/2026Sell608$4.78$2,906.24537,116View SEC Filing Icon  
See Full Table

Zhenyu Xu Buying and Selling Activity at SOPHiA GENETICS

This chart shows Zhenyu Xu's buying and selling at SOPHiA GENETICS by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

SOPHiA GENETICS Company Overview

SOPHiA GENETICS logo
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.
Read More

Today's Range

Now: $5.12
Low: $4.92
High: $5.28

50 Day Range

MA: $4.81
Low: $4.10
High: $5.28

2 Week Range

Now: $5.12
Low: $2.59
High: $5.70

Volume

88,961 shs

Average Volume

166,725 shs

Market Capitalization

$350.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.01